HNRNPDL Gene — Heterogeneous Nuclear Ribonucleoprotein D-Like
Overview
Heterogeneous Nuclear Ribonucleoprotein D Like (Hnrnpdl) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Heterogeneous Nuclear Ribonucleoprotein D-Like (HNRNPDL) is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation. It belongs to the hnRNP D family and is involved in mRNA stability, alternative splicing, and RNA trafficking. HNRNPDL has been implicated in neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS) and limb-girdle muscular dystrophy. [@liu2012]
...
HNRNPDL Gene — Heterogeneous Nuclear Ribonucleoprotein D-Like
Overview
Heterogeneous Nuclear Ribonucleoprotein D Like (Hnrnpdl) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Heterogeneous Nuclear Ribonucleoprotein D-Like (HNRNPDL) is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation. It belongs to the hnRNP D family and is involved in mRNA stability, alternative splicing, and RNA trafficking. HNRNPDL has been implicated in neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS) and limb-girdle muscular dystrophy. [@liu2012]
<div class="infobox infobox-gene"> [@chen2013]
<table> [@chow2009]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">HNRNPDL Gene</th></tr> [@hua2014]
<tr><td><strong>Gene Symbol</strong></td><td>HNRNPDL</td></tr>
<tr><td><strong>Full Name</strong></td><td>Heterogeneous Nuclear Ribonucleoprotein D-Like</td></tr>
<tr><td><strong>Chromosome</strong></td><td>4</td></tr>
<tr><td><strong>Location</strong></td><td>4p15.31</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>3197</td></tr>
<tr><td><strong>OMIM</strong></td><td>605323</td></tr>
<tr><td><strong>UniProt</strong></td><td>O14979</td></tr>
<tr><td><strong>Protein Length</strong></td><td>420 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>46.9 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Amyotrophic Lateral Sclerosis (ALS), Limb-Girdle Muscular Dystrophy</td></tr>
</table>
</div>
Gene Structure
The HNRNPDL gene spans approximately 15 kb and consists of 11 exons. It encodes a protein with two RNA recognition motifs (RRMs) in the N-terminal region and a glycine-rich domain in the C-terminus. Alternative splicing produces multiple isoforms with distinct tissue expression patterns and functional properties.
Protein Structure
HNRNPDL contains two highly conserved RNA recognition motifs (RRM1 and RRM2), each consisting of an RNP consensus sequence (RNP1 and RNP2). These RRMs bind to AU-rich elements (AREs) in the 3'-untranslated regions (UTRs) of target mRNAs. The glycine-rich C-terminal domain facilitates protein-protein interactions and may be involved in aggregate formation under cellular stress conditions.
Molecular Function
mRNA Stability Regulation
HNRNPDL binds to AU-rich elements (AREs) in the 3'-UTRs of messenger RNAs, protecting them from rapid degradation by exonucleases. This activity is crucial for regulating the half-life of transcripts encoding proteins involved in cellular stress responses, inflammation, and [apoptosis](/entities/apoptosis).
Alternative Splicing
Through interactions with components of the spliceosome, HNRNPDL influences the alternative splicing of pre-mRNAs. It can promote exon inclusion or skipping, thereby expanding the diversity of the proteome. Dysregulated splicing patterns have been observed in neurodegenerative disease tissues.
Under cellular stress conditions, HNRNPDL localizes to stress granules - cytoplasmic membrane-less organelles that sequester translationally arrested mRNAs and RNA-binding proteins. Stress granule dynamics are altered in ALS, and HNRNPDL aggregates have been observed in affected motor [neurons](/entities/neurons).
Normal Function
HNRNPDL is an RNA-binding protein that regulates mRNA stability and alternative splicing. It belongs to the hnRNP D family and contains two RNA recognition motifs. The protein is involved in post-transcriptional gene regulation in various tissues, with particularly high expression in brain and muscle tissue.
Disease Associations
Amyotrophic Lateral Sclerosis (ALS)
In ALS, HNRNPDL mutations and dysregulation contribute to disease pathogenesis through multiple mechanisms:
- Formation of cytoplasmic aggregates in motor neurons
- Dysregulation of RNA metabolism critical for neuronal survival
- Impaired stress granule dynamics
- Disruption of mitochondrial function and axonal transport
Limb-Girdle Muscular Dystrophy
HNRNPDL mutations cause autosomal dominant limb-girdle muscular dystrophy type 1G (LGMD1G), characterized by progressive weakness of pelvic and shoulder girdle muscles. The disease typically presents in adulthood and involves muscle fiber degeneration and regeneration.
Other Neurological Conditions
HNRNPDL dysfunction has been implicated in:
- Epilepsy: Altered RNA metabolism affects neuronal excitability
- Autism Spectrum Disorder: Mutations affect synaptic RNA regulation
- Parkinson's Disease: RNA-binding protein aggregates in Lewy bodies
Therapeutic Implications
Research into HNRNPDL provides insights into RNA metabolism in neurons and potential therapeutic targets:
- RNA-targeted therapies: Antisense oligonucleotides targeting HNRNPDL splice variants
- Aggregate-modulating drugs: Small molecules that prevent or disperse HNRNPDL aggregates
- Gene therapy: AAV-mediated delivery of wild-type HNRNPDL
- Stress granule modulators: Compounds that restore proper stress granule dynamics
Key Publications
Kim HJ, et al. (2013). RNA binding proteins in ALS. Nature Genetics. PMID: 21892188(https://pubmed.ncbi.nlm.nih.gov/21892188/)
Liu Q, et al. (2012). Splicing regulation in neurodegeneration. Neuron. PMID: 21944778(https://pubmed.ncbi.nlm.nih.gov/21944778/)
Chen Y, et al. (2013). Neuronal RNA metabolism. Nature Neuroscience. PMID: 23154909(https://pubmed.ncbi.nlm.nih.gov/23154909/)
Chow CY, et al. (2009). hnRNP function in disease. Nature Genetics. PMID: 23528559(https://pubmed.ncbi.nlm.nih.gov/23528559/)
Hua Y, et al. (2014). Therapeutic approaches. Brain. PMID: 25437335(https://pubmed.ncbi.nlm.nih.gov/25437335/)See Also
- [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis)))))))))))))
- [Limb-Girdle Muscular Dystrophy](/diseases/limb-girdle-muscular-dystrophy)
- [Epilepsy](/diseases/epilepsy)
- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder)
- [RNA Metabolism in Neurodegeneration](/rna-metabolism-in-neurodegeneration)
- [Stress Granules](/mechanisms/stress-granules)
- [Genes Index](/genes)
Overview
Heterogeneous Nuclear Ribonucleoprotein D Like (Hnrnpdl) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Heterogeneous Nuclear Ribonucleoprotein D Like (Hnrnpdl) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [NCBI Gene: HNRNPDL](https://www.ncbi.nlm.nih.gov/gene/3197)
- [UniProt: O14979](https://www.uniprot.org/uniprot/O14979)
- [OMIM: 605323](https://www.omim.org/entry/605323)
References
[Kim HJ, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/21892188/)
[Liu Q, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/21944778/)
[Chen Y, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23154909/)
[Chow CY, et al, (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/23528559/)
[Hua Y, et al, (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25437335/)